Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective

Heart Lung. 2020 Nov-Dec;49(6):688-691. doi: 10.1016/j.hrtlng.2020.08.012. Epub 2020 Aug 20.

Abstract

COVID-19 is impacting the cardiovascular community both here in the United States and globally. The rapidly emerging cardiac complications have heightened implications for those with underlying cardiovascular disease. We describe an early case of COVID-19 in a left ventricular assist device recipient in the United States. We discuss our clinical management during the initial admission, outpatient management, and a unique complication of this disease over a 40-day disease course.

Keywords: COVID-19; Coronavirus; LVAD; Pandemic; SARS-CoV-2; Ventricular assist device.

Publication types

  • Case Reports

MeSH terms

  • Betacoronavirus
  • Blood Pressure / physiology
  • COVID-19
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / physiopathology
  • Coronavirus Infections* / therapy
  • Female
  • Heart Rate / physiology
  • Heart-Assist Devices*
  • Humans
  • Middle Aged
  • Pandemics*
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / physiopathology
  • Pneumonia, Viral* / therapy
  • SARS-CoV-2